HAOHAI BIOTEC (06826) spent 837,000 Hong Kong dollars to repurchase 30,500 shares on December 5th.
Haohai Biotechnology (06826) announced that on December 5, 2025, the company spent HK$837,000 to repurchase 30,500 shares at a repurchase price of HK$27.26-27.5 per share.
HAOHAI BIOTEC (06826) announced that on December 5, 2025, the company has spent 837,000 Hong Kong dollars to repurchase 30,500 shares at a repurchase price of 27.26-27.5 Hong Kong dollars per share.
Related Articles
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Guosen: RWA welcomes the era of strict supervision.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Guosen: RWA welcomes the era of strict supervision.
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
